Annovis Bio Inc.
(ANVS)
undefined
undefined%
At close: undefined
5.49
4.37%
Pre-market Dec 16, 2024, 04:00 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -56.20M | -25.33M | -14.49M | -5.46M | -990.98K | -713.87K | -682.35K |
| Depreciation & Amortization | - | - | - | 129.00K | 1.19M | - | - |
| Stock-Based Compensation | 4.63M | 9.15M | 4.70M | 1.86M | 8.48K | 82.73K | 48.49K |
| Other Working Capital | 2.44M | -4.41M | 311.13K | 294.95K | -547.57K | 75.22K | 34.55K |
| Other Non-Cash Items | 9.17M | 5.88M | 4.35M | 27.02K | 84.43K | 85.41K | 11.58K |
| Deferred Income Tax | - | - | - | -129.00K | -1.19M | - | - |
| Change in Working Capital | 2.44M | -1.14M | 657.35K | -400.71K | 421.53K | 72.53K | 96.37K |
| Operating Cash Flow | -39.97M | -17.31M | -9.13M | -3.97M | -476.54K | -558.61K | -537.48K |
| Capital Expenditures | - | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - | - |
| Purchase of Investments | - | - | - | - | - | - | - |
| Sales Maturities Of Investments | - | - | - | - | - | - | - |
| Other Investing Acitivies | - | - | - | - | - | - | - |
| Investing Cash Flow | - | - | - | - | - | - | - |
| Debt Repayment | - | - | - | - | 530.00K | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - |
| Other Financial Acitivies | 458.38K | 4.61K | 95.10K | 9.22K | -86.91K | 490.10K | 656.50K |
| Financial Cash Flow | 17.34M | 4.61K | 46.74M | 12.04M | 443.09K | 246.45K | 332.50K |
| Net Cash Flow | -22.62M | -17.31M | 37.61M | 8.07M | -33.45K | -312.16K | -204.99K |
| Free Cash Flow | -39.97M | -17.31M | -9.13M | -3.97M | -476.54K | -558.61K | -537.48K |